Direct Oral Anticoagulants and Cancer Thrombosis: What APs Need to Know

Patients with cancer are at high risk for developing cancer-associated blood clots. Mailey L. Wilks, DNP, APRN, NP-C, led a session at JADPRO Live Virtual 2021 on the risk of venous thromboembolism in patients with cancer, available anticoagulants, with a focus on direct oral anticoagulants, and wha...

Descripción completa

Detalles Bibliográficos
Autor principal: Wilks, Mailey L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2022
Materias:
Meeting Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126329/
https://www.ncbi.nlm.nih.gov/pubmed/35663169
http://dx.doi.org/10.6004/jadpro.2022.13.3.14
_version_ 1784712102791872512
author Wilks, Mailey L.
author_facet Wilks, Mailey L.
author_sort Wilks, Mailey L.
collection PubMed
description Patients with cancer are at high risk for developing cancer-associated blood clots. Mailey L. Wilks, DNP, APRN, NP-C, led a session at JADPRO Live Virtual 2021 on the risk of venous thromboembolism in patients with cancer, available anticoagulants, with a focus on direct oral anticoagulants, and what advanced practitioners should know about the prevention and the treatment of venous thromboembolism.
format Online
Article
Text
id pubmed-9126329
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Harborside Press LLC
record_format MEDLINE/PubMed
spelling pubmed-91263292022-06-04 Direct Oral Anticoagulants and Cancer Thrombosis: What APs Need to Know Wilks, Mailey L. J Adv Pract Oncol Meeting Reports Patients with cancer are at high risk for developing cancer-associated blood clots. Mailey L. Wilks, DNP, APRN, NP-C, led a session at JADPRO Live Virtual 2021 on the risk of venous thromboembolism in patients with cancer, available anticoagulants, with a focus on direct oral anticoagulants, and what advanced practitioners should know about the prevention and the treatment of venous thromboembolism. Harborside Press LLC 2022-04 2022-05-23 /pmc/articles/PMC9126329/ /pubmed/35663169 http://dx.doi.org/10.6004/jadpro.2022.13.3.14 Text en © 2022 Harborside™ https://creativecommons.org/licenses/by-nc-nd/3.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Reports
Wilks, Mailey L.
Direct Oral Anticoagulants and Cancer Thrombosis: What APs Need to Know
title Direct Oral Anticoagulants and Cancer Thrombosis: What APs Need to Know
title_full Direct Oral Anticoagulants and Cancer Thrombosis: What APs Need to Know
title_fullStr Direct Oral Anticoagulants and Cancer Thrombosis: What APs Need to Know
title_full_unstemmed Direct Oral Anticoagulants and Cancer Thrombosis: What APs Need to Know
title_short Direct Oral Anticoagulants and Cancer Thrombosis: What APs Need to Know
title_sort direct oral anticoagulants and cancer thrombosis: what aps need to know
topic Meeting Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126329/
https://www.ncbi.nlm.nih.gov/pubmed/35663169
http://dx.doi.org/10.6004/jadpro.2022.13.3.14
work_keys_str_mv AT wilksmaileyl directoralanticoagulantsandcancerthrombosiswhatapsneedtoknow

Ejemplares similares